Despite this, it is apparent that BPC 157 has huge potential and following further development has promise as a therapy to conservatively treat or aid recovery in hypovascular and hypocellular soft tissues such as tendon and ligaments
While sublingual and oral spray formulations are available, there is no robust evidence that they offer superior absorption compared to standard oral tablets
(As a side note, one way that cells can enter senescence is by telomere shortening
Clinical efficacy in humans is still being researched
Clinical applications have shown remarkable efficacy in treating age-related conditions including retinal degeneration, with 90% of patients with retinitis pigmentosa experiencing positive clinical outcomes
The compatibility assessment applies to the entire GLP-1 receptor agonist class, including semaglutide, tirzepatide, and liraglutide